Revive Therapeutics's total assets for Q2 2024 were C$9.72M, a decrease of -3.31% from the previous quarter. TSE:RVV total liabilities were C$3.32M for the fiscal quarter, a 0.96% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.